Margolin, K A <br/><br/>
Interleukin-2 in the treatment of renal cancer.  [electronic resource] 

 -  Seminars in oncology  Apr 2000 
 - 194-203 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0093-7754 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Carcinoma, Renal Cell--immunology<br/>Clinical Trials, Phase I as Topic<br/>Combined Modality Therapy<br/>Drug Administration Schedule<br/>Humans<br/>Interleukin-2--administration & dosage<br/>Kidney Neoplasms--immunology<br/>Killer Cells, Lymphokine-Activated--drug effects<br/>Nephrectomy<br/>Signal Transduction--drug effects<br/>Survival Rate<br/>Thyroiditis, Autoimmune--chemically induced